Screening and overdiagnosis communication and ethics

Summary

An ongoing cluster of empirical and philosophical projects undertaken mainly in collaboration with colleagues at the University of Sydney and Macquarie University in Australia.

Contact

vikki.entwistle@abdn.ac.uk 

Status

Analysis ongoing

Publications

Rogers W, Craig W, Entwistle VA. Ethical issues raised by thyroid cancer over-diagnosis: the advantages of public health over clinical approaches. Bioethics, 2017, 31 (8): 590-598. DOI: 10.1111/bioe.12383

Pickles K, Carter SM, Rychetnik L, Entwistle VA. Doctors’ perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study. BMJ Open, 2016; 6 e011932. DOI 10.1136/bmjopen-2016-011932

Pickles K, Carter SM, Rychetnick L, McCaffery K, Entwistle VA. General practitioners’ experiences of, and responses to, uncertainty in prostate cancer screening: Insights from a qualitative study. PLoS One, 2016, 11(4): e0153299. doi:10.1371/journal.pone.0153299

Forbes LJL, Ramirez AJ and the Expert Group on Information about Breast Screening (Archer M,  Cooke J,  Coulter  A,  Dewar  JA ,  Entwistle V,  Felton R,  Kirby J,  Jones A,  Michell M,  Patnick J,  Reed M,  Richards M,  Rule J,  Spiegelhalter D,  Spika D,  Whelehan P,  Wilson RM). Offering informed choice about breast screening.Journal of Medical Screening 2014; 21: 194-200.

Rychetnik L, Carter SM, Abelson J, Thornton H, Barratt A, Entwistle VA, MacKenzie G, Salkeld G, Glasziou P. Enhancing citizen engagement in cancer screening through deliberative democracy. JNCI – Journal of the National Cancer Institute, 2013; 105(6): 380-6. DOI: 10.1093/jnci/djs649 

Entwistle VA, Carter SM, Trevena L, Flitcroft K, Irwig L, McCaffery K, Salkeld G. Communication about screening: a proposed new direction. BMJ, 2008; 337 (221) a1591.